✦ LIBER ✦
1172-69 Early use of small molecule platelet glycoprotein IIb/IIIa inhibitors for all acute coronary syndrome patients is superior to selective use of abciximab for only those requiring percutaneous coronary interventions
✍ Scribed by Ruchira Glaser; Henry Glick; Howard C Herrmann; Stephen E Kimmel
- Book ID
- 119549388
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 81 KB
- Volume
- 43
- Category
- Article
- ISSN
- 1558-3597
No coin nor oath required. For personal study only.